Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P H de Mulder

Showing results (61-70 of 137) with videos related to

Pageof 14
Sort By:
Progress in Clinical and Biological Research|January 1, 1990
New prospects in the management of metastatic renal cell carcinoma. Experimental and clinical dataF M Debruyne, M P Franssen, A J Beniers, et al.
Lancet (London, England)|January 28, 1989
Hypothyroidism and goitre during interleukin-2 therapy without LAK cellsP A van Liessum, P H de Mulder, E J Mattijssen, et al.
British Journal of Cancer|February 1, 1996
Phase II study of rhizoxin in squamous cell head and neck cancer. The EORTC Early Clinical Trials GroupJ Verweij, J Wanders, T Gil, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Effects of doxorubicin on maturation of human monocytes in adherent and non-adherent culturesR C van Schie, P H de Mulder, H van Rennes, et al.
Anticancer Research|May 1, 1991
In vitro studies on the influence of doxorubicin in combination with recombinant interferon-gamma on human monocytesR C Van Schie, P H De Mulder, H G Verstraten, et al.
Cancer|June 1, 1984
Monocyte-mediated-antibody-dependent cellular cytotoxicity in malignant lymphoma and solid tumorsP H de Mulder, B E de Pauw, E C van de Ven, et al.
Head & Neck|July 1, 1992
Cisplatin-based chemotherapy in advanced adenoid cystic carcinoma of the head and neckL D de Haan, P H De Mulder, J B Vermorken, et al.
British Journal of Urology|October 1, 1990
The importance of prognostic factors in the individual treatment of patients with disseminated germ cell tumoursP F Mulders, G O Oosterhof, C Boetes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 6, 2001
Phase II EORTC trial with 5-fluorouracil, cisplatin and interferon-alpha as second-line treatment of advanced transitional cell cancer of the urothelial tractP H De Mulder, C Theodore, A Sella, et al.
Clinical and Experimental Immunology|December 1, 1983
Characterization of monocyte maturation in adherent and suspension cultures and its application to study monocyte differentiation in Hodgkin's diseaseP H de Mulder, H van Rennes, P D Mier, et al.
Pageof 14

Showing results (61-70 of 137) with videos related to

Sort By:
Pageof 14
Progress in Clinical and Biological Research|January 1, 1990
New prospects in the management of metastatic renal cell carcinoma. Experimental and clinical dataF M Debruyne, M P Franssen, A J Beniers, et al.
Lancet (London, England)|January 28, 1989
Hypothyroidism and goitre during interleukin-2 therapy without LAK cellsP A van Liessum, P H de Mulder, E J Mattijssen, et al.
British Journal of Cancer|February 1, 1996
Phase II study of rhizoxin in squamous cell head and neck cancer. The EORTC Early Clinical Trials GroupJ Verweij, J Wanders, T Gil, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Effects of doxorubicin on maturation of human monocytes in adherent and non-adherent culturesR C van Schie, P H de Mulder, H van Rennes, et al.
Anticancer Research|May 1, 1991
In vitro studies on the influence of doxorubicin in combination with recombinant interferon-gamma on human monocytesR C Van Schie, P H De Mulder, H G Verstraten, et al.
Cancer|June 1, 1984
Monocyte-mediated-antibody-dependent cellular cytotoxicity in malignant lymphoma and solid tumorsP H de Mulder, B E de Pauw, E C van de Ven, et al.
Head & Neck|July 1, 1992
Cisplatin-based chemotherapy in advanced adenoid cystic carcinoma of the head and neckL D de Haan, P H De Mulder, J B Vermorken, et al.
British Journal of Urology|October 1, 1990
The importance of prognostic factors in the individual treatment of patients with disseminated germ cell tumoursP F Mulders, G O Oosterhof, C Boetes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 6, 2001
Phase II EORTC trial with 5-fluorouracil, cisplatin and interferon-alpha as second-line treatment of advanced transitional cell cancer of the urothelial tractP H De Mulder, C Theodore, A Sella, et al.
Clinical and Experimental Immunology|December 1, 1983
Characterization of monocyte maturation in adherent and suspension cultures and its application to study monocyte differentiation in Hodgkin's diseaseP H de Mulder, H van Rennes, P D Mier, et al.
Pageof 14